Applied
UV's
Airocide™ System
Installed in
Uruguayan
School
System
-
60
Airocide®
Units
now
operating
in
Colegio Santa Elena
-
Installation
is expected to be first of many as international expansion strategy
accelerates
-
Installation
in school system follows recently
awarded $3.5
million minimum
first year purchase commitment to
Applied
UV from
South
Africa distributor
Mount Vernon, NY
// June 1, 2021 -- InvestorsHub
NewsWire -- Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), an
infection control technology company that applies the power of
narrow-range ultraviolet light ("UVC") for surface areas and
catalytic bioconversion technology for air purification to destroy
pathogens safely, thoroughly, and automatically,
today
announced
that
its
distributor has installed 60 Airocide® units in Colegio
Santa Elena, a
private school located in Montevideo, Uruguay. Applied
UV expects that this installation
will
serve as a
prototype
project for the
expansion
of the
Airocide®
solution
into
the
school
systems
located in South America.
The challenge for
Santa Elena school administrators was the same one faced by all
school administrators around the world: the requirement of physical
distance protocols for schools severely reduces the goal of
full attendance. To address
social distancing
requirements, the Santa Elena school
collaborated
with
engineers, researchers,
and
the Pasteur
Institute, to analyze the possibility of using similar air purification
technology deployed in places where pathogen control
was essential, such as operating theaters
and
health care
facilities. After conducting internal
testing, Colegio
Santa Elena determined that adding air purification systems to
classrooms could reduce or eliminate the viruses and bacteria that
circulate at different times of the year, improve air quality, and
better protect the health of students and teachers.
"The
evidence
continues to mount on the academic
toll remote learning has taken on
children,"
said
Q Saeed, CEO of Applied UV.
"While
many recommended
mitigation measures in schools may continue for some time,
the need for more
permanent and sustainable solutions continues to grow.
There is
increasingly universal recognition that infections can be prevented
by improving indoor ventilation systems that control hazards of
airborne transmission of respiratory infections. We are thrilled that the
Airocide® system has been chosen to be
part of the solution to reopening the Colegio
Santa Elena to
full
attendance.
We are eager to share this success story with the entire
Uruguayan
school
system, which currently
has 1,400
urban schools with an average of eight classrooms per
school."
Airocide® System
The Airocide®
System, originally developed by NASA with assistance from the
University of Wisconsin at Madison,
is an airborne pathogen killing technology that uses a patented
combination of UVC and a proprietary, titanium dioxide based
photocatalyst. Listed as an FDA Class II Medical device, the
Airocide®
technology is clinically proven and field tested to
kill/remove/eliminate airborne pathogenic and non-pathogenic
microorganisms, allergens, odors and harmful VOCs in a variety of
applications and industries including healthcare, hospitality,
grocery chains, wineries, commercial real estate, schools, dental
offices and homes. Airocide® air purifiers are available
at www.airocide.com.
About
Applied UV
Applied
UV is focused on the development and acquisition of technology that
address infection
control
in the
healthcare, hospitality, commercial and municipal
markets.
The Company has two wholly owned subsidiaries -
SteriLumen,
Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works").
SteriLumen's
connected platform for Data Driven Disinfection™
applies
the power of ultraviolet
light (UVC) to
destroy pathogens safely, thoroughly, and
automatically,
addressing the challenge of healthcare-acquired
infections ("HAIs").
Targeted
for use in facilities that have high customer turnover such as
hospitals, hotels,
commercial facilities,
and other public spaces,
the
Company's Lumicide™
platform
uses UVC LEDs
in
several patented designs
for
infection
control
in
and around
high-traffic areas,
including sinks and restrooms,
killing bacteria,
viruses,
and other pathogens residing on hard surfaces
within
devices'
proximity.
The Company's patented in-drain disinfection
device,
Lumicide Drain,
is the only product
on the market
that addresses this critical pathogen intensive location.
SteriLumen's Airocide® products for air purification,
developed by NASA and FDA Cleared as class II medical devices,
utilize a proprietary photo-catalytic bioconversion technology that
draws air into a reaction chamber that converts damaging molds,
microorganisms, dangerous pathogens, destructive VOCs and
biological gasses into harmless water vapor without producing ozone
or other harmful byproducts. Airocide®
applications include healthcare, hospitality, grocery chains, wine
making facilities, commercial real estate, schools, dental
offices,
and homes.
For more
information about Applied UV, Inc., and its subsidiaries, please
visit the following websites:
https://www.applieduvinc.com/;
https://sterilumen.com/; and,
https://munnworks.com/.
Forward-Looking
Statements
The information
contained herein may contain "forward-looking statements."
Forward-looking statements reflect the current view about future
events. When used in this press release, the words "anticipate,"
"believe," "estimate," "expect," "future," "intend," "plan," or the
negative of these terms and similar expressions, as they relate to
us or our management, identify forward-looking statements. Such
statements include, but are not limited to, statements contained in
this press release relating to the view of management of Applied UV
concerning its business strategy, future operating results and
liquidity and capital resources outlook. Forward-looking statements
are based on the Company's current expectations and assumptions
regarding its business, the economy and other future conditions.
Because forward–looking statements relate to the future, they are
subject to inherent uncertainties, risks and changes in
circumstances that are difficult to predict. The Company's actual
results may differ materially from those contemplated by the
forward-looking statements. They are neither statements of
historical fact nor guarantees of assurance of future performance.
We caution you therefore against relying on any of these
forward-looking statements. Factors or events that could cause the
Company's actual results to differ may emerge from time to time,
and it is not possible for the Company to predict all of them. The
Company cannot guarantee future results, levels of activity,
performance, or achievements. Except as required by applicable law,
including the securities laws of the United States, the Company
does not intend to update any of the forward-looking statements to
conform these statements to actual results.
Applied UV
Investor Relations
TraDigital IR
Kevin
McGrath
TraDigital IR
+1-646-418-7002
kevin@tradigitalir.com